Millennium Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.7M | Buy |
2,338,700
+1,203,500
| +106% | +$32M | 0.03% | 669 |
|
|
2025
Q4 | $28.3M | Sell |
1,135,200
-508,900
| -31% | -$12.8M | 0.01% | 1235 |
|
|
2025
Q3 | $41.9M | Sell |
1,644,100
-1,623,600
| -50% | -$40.1M | 0.02% | 996 |
|
|
2025
Q2 | $79.2M | Buy |
3,267,700
+506,700
| +18% | +$11.8M | 0.04% | 537 |
|
|
2025
Q1 | $70M | Buy |
2,761,000
+1,116,000
| +68% | +$29.2M | 0.04% | 555 |
|
|
2024
Q4 | $43.6M | Sell |
1,645,000
-789,500
| -32% | -$21.4M | 0.02% | 875 |
|
|
2024
Q3 | $70.5M | Sell |
2,434,500
-2,284,100
| -48% | -$66.6M | 0.03% | 617 |
|
|
2024
Q2 | $132M | Buy |
4,718,600
+338,900
| +8% | +$9.33M | 0.06% | 319 |
|
|
2024
Q1 | $122M | Buy |
4,379,700
+273,000
| +7% | +$7.58M | 0.05% | 370 |
|
|
2023
Q4 | $118M | Buy |
4,106,700
+1,320,400
| +47% | +$39.9M | 0.05% | 353 |
|
|
2023
Q3 | $92.4M | Buy |
2,786,300
+197,100
| +8% | +$6.97M | 0.05% | 399 |
|
|
2023
Q2 | $95M | Buy |
2,589,200
+1,805,400
| +230% | +$70.3M | 0.05% | 387 |
|
|
2023
Q1 | $32M | Sell |
783,800
-198,500
| -20% | -$8.57M | 0.02% | 982 |
|
|
2022
Q4 | $50.3M | Buy |
982,300
+399,300
| +68% | +$19.1M | 0.03% | 749 |
|
|
2022
Q3 | $25.5M | Sell |
583,000
-690,000
| -54% | -$33.5M | 0.02% | 1124 |
|
|
2022
Q2 | $66.7M | Sell |
1,273,000
-150,000
| -11% | -$7.64M | 0.04% | 484 |
|
|
2022
Q1 | $73.7M | Sell |
1,423,000
-1,006,900
| -41% | -$52.2M | 0.04% | 481 |
|
|
2021
Q4 | $132M | Buy |
2,429,900
+1,113,700
| +85% | +$55.2M | 0.07% | 249 |
|
|
2021
Q3 | $48.2M | Sell |
1,316,200
-993,300
| -43% | -$44M | 0.03% | 653 |
|
|
2021
Q2 | $82.8M | Buy |
+2,309,500
| New | +$89.8M | 0.05% | 383 |
|
|
2021
Q1 | – | Sell |
-1,108,100
| Closed | -$11M | – | 6383 |
|
|
2020
Q4 | $11M | Buy |
1,108,100
+203,663
| +23% | +$7.47M | 0.01% | 1619 |
|
|
2020
Q3 | $31.5K | Buy |
904,437
+313,459
| +53% | +$11M | 0.04% | 529 |
|
|
2020
Q2 | $18.3M | Sell |
590,978
-305,344
| -34% | -$10.4M | 0.03% | 788 |
|
|
2020
Q1 | $27.8M | Buy |
896,322
+810,632
| +946% | +$27.6M | 0.06% | 319 |
|
|
2019
Q4 | $3.19M | Sell |
85,690
-143,133
| -63% | -$5.1M | ﹤0.01% | 2284 |
|
|
2019
Q3 | $7.8M | Sell |
228,823
-531,322
| -70% | -$19.3M | 0.01% | 1461 |
|
|
2019
Q2 | $31.2M | Buy |
+760,145
| New | +$30.2M | 0.05% | 548 |
|
|
2018
Q2 | – | Sell |
-52,700
| Closed | -$1.77M | – | 4081 |
|
|
2018
Q1 | $1.77M | Buy |
+52,700
| New | +$1.81M | ﹤0.01% | 2389 |
|
|
2015
Q2 | – | Sell |
-6,640
| Closed | -$219K | – | 3708 |
|
|
2015
Q1 | $219K | Buy |
+6,640
| New | +$211K | ﹤0.01% | 3252 |
|
|
2014
Q3 | – | Sell |
-20,448
| Closed | -$576K | – | 3935 |
|
|
2014
Q2 | $576K | Buy |
+20,448
| New | +$583K | ﹤0.01% | 2511 |
|
Other funds holding PFE
VCM
VPM
Millennium Management's PFE Position: Q1 2026 in Review
Millennium Management reduced its Pfizer (PFE) stake by 95% in Q1 2026, selling an estimated $49.3M and leaving 96,364 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3575.
Millennium Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $557M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Millennium Management held 96,364 shares of Pfizer worth $2.71M as of Q1 2026.
- Millennium Management sold 1,851,131 Pfizer shares in Q1 2026, an estimated $49.3M.
- Pfizer made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3575 holding.
- Millennium Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Pfizer position peaked at $557M in Q2 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.